SIX Swiss Exchange · Healthcare
Invest in Lonza stock from India
Indian and foreign residents can buy Lonza (LONN) shares directly through Paasa.
By Paasa · Updated
Lonza at a glance
- Price
- CHF 563.40-CHF 13.80 (2.39%)
- Market cap
- CHF 39.35B
- Day range
- CHF 563.40 – CHF 570.80
- P/E
- -365.84
- Dividend yield
- 0.89%
- Volume
- 130.52K
- 1 month
- +1.33%
- 6 months
- +10.77%
- YTD
- +4.76%
- 1 year
- +3.41%
- 5 years
- -18.54%
Lonza statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 6.5B | CHF 5.5B | CHF 6.7B | CHF 6.2B | CHF 5.4B |
| Gross profit | CHF 2.3B | CHF 2.0B | CHF 1.8B | CHF 2.3B | CHF 2.0B |
| Operating income | CHF 1.4B | CHF 1.1B | CHF 854.0M | CHF 1.3B | CHF 819.0M |
| Net income | −CHF 275.0M | CHF 636.0M | CHF 654.0M | CHF 1.2B | CHF 2.9B |
| Earnings per share | −CHF 3.93 | CHF 8.93 | CHF 8.88 | CHF 16.37 | CHF 39.65 |
| EBITDA | CHF 2.0B | CHF 1.7B | CHF 1.5B | CHF 1.9B | CHF 1.3B |
| Total assets | CHF 19.0B | CHF 19.7B | CHF 16.8B | CHF 17.4B | CHF 16.5B |
| Total debt | CHF 4.5B | CHF 5.1B | CHF 3.1B | CHF 2.6B | CHF 2.7B |
| Cash and short-term investments | CHF 719.0M | CHF 1.7B | CHF 1.7B | CHF 2.2B | CHF 3.2B |
| Shareholders' equity | CHF 9.1B | CHF 9.3B | CHF 9.5B | CHF 10.6B | CHF 9.8B |
| Operating cash flow | CHF 1.2B | CHF 1.3B | CHF 1.4B | CHF 1.0B | CHF 1.2B |
| Free cash flow | −CHF 204.0M | −CHF 143.0M | −CHF 263.0M | −CHF 833.0M | −CHF 126.0M |
| Capital expenditure | −CHF 1.4B | −CHF 1.4B | −CHF 1.6B | −CHF 1.9B | −CHF 1.3B |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Samsung Biologics | 207940.KS | ₩1,219,000.00 | ₩56.43T |
| WuXi Biologics (Cayman) | 2269.HK | HK$54.10 | HK$224.17B |
| Genscript Biotech | 1548.HK | HK$40.70 | HK$88.92B |
| Pharmaron Beijing | 300759.SZ | $43.75 | $64.63B |
| Bachem | BANB.SW | CHF 77.90 | CHF 5.84B |
| Dottikon ES | DESN.SW | CHF 256.50 | CHF 3.55B |
| Siegfried | SFZN.SW | CHF 67.60 | CHF 2.96B |
| PolyPeptide | PPGN.SW | CHF 43.90 | CHF 1.45B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 1 buy · 2 hold · 0 sell. Consensus: Hold.
Published sell-side 12-month targets in CHF, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Lonza from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search LONN and buy
Find Lonza by name or by its ticker, LONN, and place your order.
Why invest in Lonza from India
What Lonza does
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. Lonza operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Lonza stock from India?
Yes. Indian residents and NRIs can buy Lonza (LONN) shares directly through Paasa. Lonza is listed on the SIX Swiss Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Lonza shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.